Bone marrow is a major site of long-term antibody production after acute viral infection - PubMed (original) (raw)
Bone marrow is a major site of long-term antibody production after acute viral infection
M K Slifka et al. J Virol. 1995 Mar.
Abstract
Antiviral antibody production is often sustained for long periods after resolution of an acute viral infection. Despite extensive documentation of this phenomenon, the mechanisms involved in maintaining long-term antibody production remain poorly defined. As a first step towards understanding the nature of long-term humoral immunity, we examined the anatomical location of antibody-producing cells during acute viral infection. Using the lymphocytic choriomeningitis virus (LCMV) model, we found that after resolution of the acute infection, when antiviral plasma cells in the spleen decline, a population of virus-specific plasma cells appears in the bone marrow and constitutes the major source of long-term antibody production. Following infection of adult mice, LCMV-specific antibody-secreting cells (ASC) peaked in the spleen at 8 days postinfection but were undetectable in the bone marrow at that time. The infection was essentially cleared by 15 days, and the ASC numbers in the spleen rapidly declined while an increasing population of LCMV-specific ASC began to appear in the bone marrow. Compared with the peak response at 8 days postinfection, time points from 30 days to more than 1 year later demonstrated greater-than-10-fold reductions in splenic ASC. In contrast, LCMV-specific plasma cell numbers in the bone marrow remained high and correlated with the high levels of antiviral serum antibody. The presence of LCMV-specific plasma cells in the bone marrow was not due to persistent infection at this site, since the virus was cleared from both the spleen and bone marrow with similar kinetics as determined by infectivity and PCR assays. The immunoglobulin G subclass profile of antibody-secreting cells derived from bone marrow and the spleen correlated with the immunoglobulin G subclass distribution of LCMV-specific antibody in the serum. Upon rechallenge with LCMV, the spleen exhibited a substantial increase in virus-specific plasma cell numbers during the early phase of the secondary response, followed by an equally sharp decline. Bone marrow ASC populations and LCMV-specific antibody levels in the serum did not change during the early phase of the reinfection, but both increased about two-fold by 15 days postchallenge. After both primary and secondary viral infections, LCMV-specific plasma cells were maintained in the bone marrow, showing that the bone marrow is a major site of long-term antibody production after acute viral infection. These results documenting long-term persistence of plasma cells in the bone marrow suggest a reexamination of our current notions regarding the half-life of plasma cells.
Similar articles
- Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection.
Slifka MK, Ahmed R. Slifka MK, et al. Ann N Y Acad Sci. 1996 Oct 25;797:166-76. doi: 10.1111/j.1749-6632.1996.tb52958.x. Ann N Y Acad Sci. 1996. PMID: 8993360 - Bone marrow contains virus-specific cytotoxic T lymphocytes.
Slifka MK, Whitmire JK, Ahmed R. Slifka MK, et al. Blood. 1997 Sep 1;90(5):2103-8. Blood. 1997. PMID: 9292550 - Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection.
Moskophidis D, Löhler J, Lehmann-Grube F. Moskophidis D, et al. J Exp Med. 1987 Mar 1;165(3):705-19. doi: 10.1084/jem.165.3.705. J Exp Med. 1987. PMID: 3546579 Free PMC article. - Analyzing Mouse B Cell Responses Specific to LCMV Infection.
Hao Y, Li Z, Wang Y, Liu X, Ye L. Hao Y, et al. Methods Mol Biol. 2018;1707:15-38. doi: 10.1007/978-1-4939-7474-0_2. Methods Mol Biol. 2018. PMID: 29388097 Review. - Limited humoral immunoglobulin E memory influences serum immunoglobulin E levels in blood.
Achatz-Straussberger G, Zaborsky N, Königsberger S, Feichtner S, Lenz S, Peckl-Schmid D, Lamers M, Achatz G. Achatz-Straussberger G, et al. Clin Exp Allergy. 2009 Sep;39(9):1307-13. doi: 10.1111/j.1365-2222.2009.03278.x. Epub 2009 May 20. Clin Exp Allergy. 2009. PMID: 19489847 Free PMC article. Review.
Cited by
- The role of immune cells settled in the bone marrow on adult hematopoietic stem cells.
Xu H, Li Y, Gao Y. Xu H, et al. Cell Mol Life Sci. 2024 Oct 5;81(1):420. doi: 10.1007/s00018-024-05445-3. Cell Mol Life Sci. 2024. PMID: 39367881 Free PMC article. Review. - Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.
Eslami M, Schuepbach-Mallepell S, Diana D, Willen L, Kowalczyk-Quintas C, Desponds C, Peter B, Vigolo M, Renevey F, Donzé O, Luther SA, Yalkinoglu Ö, Alouche N, Schneider P. Eslami M, et al. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2404309121. doi: 10.1073/pnas.2404309121. Epub 2024 Jul 11. Proc Natl Acad Sci U S A. 2024. PMID: 38990948 - Temporal dynamics and genomic programming of plasma cell fates.
Manakkat Vijay GK, Zhou M, Thakkar K, Rothrauff A, Chawla AS, Chen D, Lau LC, Gerges PH, Chetal K, Chhibbar P, Fan J, Das J, Joglekar A, Borghesi L, Salomonis N, Xu H, Singh H. Manakkat Vijay GK, et al. Nat Immunol. 2024 Jun;25(6):1097-1109. doi: 10.1038/s41590-024-01831-y. Epub 2024 May 2. Nat Immunol. 2024. PMID: 38698087 - Minimal Determinants for Lifelong Antiviral Antibody Responses in Mice from a Single Exposure to Virus-like Immunogens at Low Doses.
Wholey WY, Meyer AR, Yoda ST, Chackerian B, Zikherman J, Cheng W. Wholey WY, et al. Vaccines (Basel). 2024 Apr 11;12(4):405. doi: 10.3390/vaccines12040405. Vaccines (Basel). 2024. PMID: 38675787 Free PMC article. - Poly(I:C) and R848 ligands show better adjuvanticity to induce B and T cell responses against the antigen(s).
Tandel N, Patel D, Thakkar M, Shah J, Tyagi RK, Dalai SK. Tandel N, et al. Heliyon. 2024 Feb 27;10(5):e26887. doi: 10.1016/j.heliyon.2024.e26887. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38455541 Free PMC article.
References
- Virology. 1994 Oct;204(1):234-41 - PubMed
- Adv Immunol. 1980;30:275-331 - PubMed
- J Immunol Methods. 1992 Aug 30;153(1-2):107-13 - PubMed
- Immunol Rev. 1992 Apr;126:143-61 - PubMed
- J Infect Dis. 1991 Nov;164(5):973-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous